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ABSTRACT
In triple-negative breast cancer (TNBC), the high recurrence rate, increased 
invasion and aggressive metastatic formation dictate patient survival. We previously 
demonstrated a critical role for the Na+/H+ exchanger isoform 1 (NHE1) in controlling 
metastasis of triple-negative cells. Here, we investigated the effect of changes to three 
regulatory loci of NHE1. Two via the Ras/Raf/ERK/p90RSK pathway: p90RSK/14-3-3 
(S703A) and ERK1/2 (S766,770,771A, SSSA) and a third via a calmodulin-binding 
domain (K641,R643,645,647E, 1K3R4E). MDA-MB-231 cells with a mutation at the 
p90RSK site (S703A-NHE1) changed from a wild-type mesenchymal morphology to a 
smaller epithelial-like phenotype with a loss of expression of mesenchymal marker 
vimentin. S703A cells also had reduced metastatic potential and markedly decreased 
rates of migration, invasion, spheroid growth, anchorage-dependent and soft agar 
colony formation. Similarly, BI-D1870, a specific inhibitor of p90RSK, significantly 
inhibited the metastatic potential of highly invasive MDA-MB-231 and moderately 
invasive MDA-MB-468 TNBC cells, but was minimally effective in non-invasive Hs578T 
TNBC cells. In contrast, invasion and spheroid growth were unaffected in cells 
containing NHE1 with mutations interfering with its activation by ERK1/2 (SSSA), 
though rates of migration and colony formation were reduced. Cells with a constitutive 
activation of NHE1 via the 1K3R4E mutation exhibited higher rates of migration, 
invasion, and spheroid growth. Taken together, our data demonstrate the critical role 
of NHE1 in metastasis, and suggest a novel link between NHE1 and the expression and 
cytosolic organization of vimentin, a key factor in epithelial-mesenchymal transition, 
that is dependent on p90RSK/14-3-3-mediated activation of the exchanger.
INTRODUCTION
Metastasis is the leading cause of mortality in 
patients with breast cancer, but prognoses are often poorest 
in those diagnosed with the triple-negative breast cancer 
(TNBC) subtype. TNBC is aggressively tumorigenic, 
with high recurrence rates that show limited response to 
chemotherapy [1, 2]. Since TNBC cells lack the expression 
of estrogen, progesterone, and human epidermal growth 
factor-2 (HER2) receptors, targeted therapies dependent 
on these receptors are ineffective. A complicating factor 
in cancer cells is that acid-base homeostasis becomes 
imbalanced at the inception of oncogenic transformation 
with an increasing intracellular pH (pHi) [3, 4]. This 
intracellular alkalinization of tumor cells and the resultant 
extracellular acidification of the tumor microenvironment 
drive malignancy [5, 6]. Malignant cancer cells lose the 
polarity and cell-cell contacts typical of differentiated 
epithelial cells, instead acquiring stem cell characteristics, 
and the motile, invasive mesenchymal phenotype that 
enables dissemination out of the primary tumor and into 
the bloodstream. This complex developmental process is 
called epithelial-mesenchymal transition (EMT). Cancer-
associated EMT is reversible. This allows for the re-
differentiation of invasive cells to an epithelial phenotype 
via mesenchymal-epithelial transition (MET), a process 
that promotes cell colonization and the formation of new 
metastases at secondary sites in the body distant from the 
primary tumor [7].
The identification of promising new targets is critical 
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in the search for more efficacious and potent treatment 
regimes against TNBC. One of these targets is the Na+/
H+ exchanger isoform 1 (NHE1). NHE1 is a ubiquitously 
expressed ion transporter found in all mammalian 
cells. It regulates pH homeostasis via the electroneutral 
exchange of one intracellular H+ for one extracellular 
Na+ ion [8] and is responsible for the elevation of pHi 
in TNBC cells and for extracellular acidification of the 
tumor microenvironment [5, 6]. We recently demonstrated 
that NHE1 inhibition increases the in vitro efficacy of 
paclitaxel chemotherapy in TNBC cells and decreases 
their viability, motility, and invasiveness. Also, deletion 
of NHE1 dramatically reduced xenograft tumor growth 
of TNBC cells in vivo in athymic nude mice [9]. The 
activation of NHE1 is regulated [10] and we therefore 
sought to elucidate the underlying regulatory mechanisms 
in TNBC cells that may influence metastatic behavior. 
NHE1 has a transmembrane domain spanning 
amino acids 1-500. This region mediates ion flux, while 
the cytosolic C-terminal domain (aa 501-815) is essential 
for regulation of exchanger activity [11]. Regulation 
of NHE1 occurs through both protein binding and 
phosphorylation by various protein kinases (reviewed in 
[12]). Amino acids 636-659 span the region involved in 
the auto-inhibition of NHE1. Mutations to this region can 
prevent auto-inhibition of NHE1 and thus constitutively 
activate the protein [13]. Calmodulin, in complex with 
calcium, which binds to this portion of the C-terminal 
tail, also prevents NHE1 auto-inhibition [14]. The more 
distal region of the NHE1 C-terminal (aa 660-815) is key 
in its regulation via phosphorylation by various protein 
kinases [15, 16]. The activation of NHE1 by the Ras/Raf/
ERK/p90RSK pathway in particular is correlated with breast 
cancer progression and metastatic behaviour [17, 18]. In 
this pathway, one amino acid of interest on NHE1 is Ser703. 
Ser703 is phosphorylated by p90RSK, which stimulates 
activity in response to serum and, when phosphorylated, 
becomes a binding site for 14-3-3 regulatory proteins [18-
20]. A second region of interest related to this pathway 
is the region around the group of amino acids Ser766, 
Ser770 and Ser771. These have been identified as ERK1/2 
phosphorylation sites [21-23] and are also involved in 
activation of NHE1. 
In the present study, we investigated the effect 
of regulatory modifications to NHE1 to determine 
their involvement in the migratory, invasive, and 
colony-forming capacity of TNBC cells. We examined 
three different regulatory mutations: two were on the 
phosphorylation sites Ser703 and the group of Ser766, Ser770 
and Ser771; and the third was the high-affinity calmodulin-
binding regulatory site of NHE1. We utilized MDA-
MB-231 cells, representative of the metastatic triple-
negative clinical subtype of breast cancer. These cells have 
a mesenchymal, invasive phenotype [24]. We replaced 
the endogenous NHE1 protein [9] with mutant NHE1 
proteins: S703A, where serine 703 was changed to a non-
phosphorylatable alanine; SSSA, where serine residues 
766, 770 and 771 were altered to non-phosphorylatable 
alanine residues; and 1K3R4E, where positively-charged 
lysine 641 (1K) and arginine 643, 645 and 647 (3R) 
residues were replaced by negatively-charged glutamic 
acids (4E). This latter mutation interferes with auto-
inhibition of the membrane domain and results in the 
constitutive activation of NHE1 [14, 25]. We found that 
S703A cells changed to a more epithelial-like phenotype, 
losing expression of the intermediate filament protein 
vimentin and migratory and invasive ability. The specific 
p90RSK inhibitor of BI-D1870A mimicked effects on 
migration, invasion, and colony growth in other triple-
negative breast cancer cells. Another NHE1 hyperactive 
mutation also made MDA-MB-231 cells more metastatic. 
Our data strongly suggest that Ser703 may be a critical 
phosphorylation switch that regulates the morphology and 
EMT/MET of the highly invasive triple-negative MDA-
MB-231 breast cancer cells. Overall, this study presents 
the first evidence of a novel link between NHE1, its 
activity, and the regulation of EMT that is associated with 
the onset of breast cancer metastasis in TNBC cells. 
RESULTS
Characterization of NHE1 expression and Na+/H+ 
exchange activity in wtNHE1 and mutant NHE1-
expressing MDA-MB-231 breast cancer cells
To investigate the effect of alterations to NHE1 
regulation in triple-negative breast cancer cells, we 
replaced endogenous NHE1 with NHE1 protein containing 
mutations to various regulatory regions. MDA-MB-231 
cells deficient in NHE1 (231koNHE1) were described 
earlier [9]. We stably expressed wild-type NHE1 
(wtNHE1) and mutant NHE1 protein into these cells 
with the following mutations to the cytosolic C-terminal 
domain: Ser703Ala (S703A), Ser766,770,771Ala (SSSA) and 
Lys641Arg643,645,647Glu (1K3R4E). We used western blot 
analysis of whole cell lysates of mutant NHE1 cell lines 
to verify expression in comparison to wtNHE1 cells. 
We examined NHE1 protein expression levels in cells 
grown in either serum-supplemented (10% serum) or 
serum-depleted (0.2% serum) culture media (Figure 1a). 
Densitometric quantification was relative to that of the 
loading control (β-tubulin). The results confirmed that 
NHE1 was stably expressed in the MDA-MB-231 cells 
and, additionally, no differences in protein expression 
were observed amongst cell types with varying serum 
concentrations (P > 0.05, N = 4, Supplementary Figure 
1a).
We next examined the activity of the wild-type 
and mutant NHE1 proteins in MDA-MB-231 cells. Cells 
were subjected to 50 mM ammonium chloride-induced 
Oncotarget21093www.impactjournals.com/oncotarget
Figure 1: Characterization of wild-type and mutant NHE1 expression and Na+/H+ exchange activity in MDA-MB-231 
cells. a. Western blot analysis of cell lysates of MDA-MB-231 cells expressing wild-type and mutant NHE1 proteins. NHE1 protein 
expression was examined in wtNHE1, S703A, SSSA and 1K3R4E cells probed with anti-NHE1 antibody. Cells were grown in either 
serum supplemented (−, 10% serum, UNSTIM) or serum depleted (+, 0.2% serum, STIM) conditions for 24 hr. prior to whole cell lysis. 
One representative western blot with anti-NHE1 antibody and anti-tubulin antibody is shown. NHE1 expression from four independent 
experiments was quantified by densitometry and determined to be unchanged between wild-type and mutant NHE1 cells (Supplementary 
Figure 1a). b. and c. Determination of NHE1 activity in mutant and wild-type cells. An acute acid load was induced by treatment with 
ammonium chloride. The rate of Na+/H+ exchange was calculated from the slope of the first 20 sec. of recovery post-acid load and expressed 
as ΔpHi/sec. ΔpHi/sec values measured for each cell type were normalized to that of the unstimulated wtNHE1 control values. b, Relative 
Na+/H+ exchange rate of mutant NHE1 cells compared to wtNHE1, 231koNHE1, and NHE1++ cells where NHE1 is over-expressed, as 
described in the Materials and Methods. c, H+ flux of wild-type and mutant NHE1 cells. Cells were acidified to varying pHi and allowed to 
recover in NaCl-containing media. The rate of H+ flux (JH
+) was calculated as a product of the buffering capacities of cells (B mmol • 1-1 • 
pH unit-1; data not shown) and the rate of change of pHi over time (ΔpHi/sec) [
#P < 0.05, N = 6]. 
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acidification for 3 min. and allowed to recover in the 
presence of NaCl. Figure 1b shows NHE1 activity relative 
to the wild-type in normal (UNSTIM) or reduced serum 
(STIM). Wild-type NHE1 protein was significantly (*P > 
0.001, N = 6) activated by reduction in serum as reported 
earlier [9, 26]; loss of Na+/H+ activity in 231koNHE1 cells 
is shown for comparison. Neither the S703A nor the SSSA 
mutant proteins were significantly activated by reduction 
in serum, though there was a tendency towards an increase 
in the SSSA-expressing cells. The 1K3R4E mutant protein 
was significantly (*P > 0.001, N = 6) more active than the 
wild-type protein, comparable to Na+/H+ exchange rates 
observed in MDA-MB-231 cells over-expressing NHE1 
(NHE1++), though this activity was not further increased 
by reduction of the serum concentration. 
A more detailed analysis of NHE1 activity involved 
acidification of the various cell types to different pHi 
followed by a calculation of the rate of proton flux at 
varying ranges of pHi (Figure 1c). This analysis of NHE1 
activity showed that increased Na+/H+ exchange activity 
of 1K3R4E cells corresponded to a higher affinity for H+ 
at an acidic pHi of 6.0-6.1 (
#P > 0.05, N = 6, Figure 1c). 
We also used optical emission spectroscopy to compare 
ionic concentrations of Na+ and K+ to determine whether 
mutations to NHE1 regulation works by modulating 
intracellular and extracellular concentrations of these 
monovalent cations. In growth conditions where NHE1 
is either stimulated by serum starvation (0.2% serum) 
or unstimulated (10% serum), a significant increase in 
intracellular K+ was observed in S703A cells compared 
to wtNHE1 cells regardless of stimulation (#P < 0.05, 
+P < 0.01, N = 6, Supplementary Figure 1b). No other 
differences in intracellular or extracellular (in culture 
media) cation concentrations were observed between the 
wtNHE1 and mutant NHE1-expressing cells.
Figure 2: Comparison of morphology of mutant and wild-type NHE1-expressing MDA-MB-231 cells. The morphology 
of mutant NHE1 cells was compared to wtNHE1 and 231koNHE1 cells by microscopy a. and flow cytometry (b, c). a. Bright-field images 
showing fixed cells with Hoechst nuclear staining (blue). Scale bars represent 50 μm at 20X magnification. b. and c. Quantification of 
differences in cell size and granularity. b. Dot plots showing cell size (FSC-A) versus granularity (SSC-A), and c., histogram overlays of 
size vs. number of cells. 
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Effect of mutations to NHE1 on MDA-MB-231 
breast cancer cell morphology
Replacement of the wild-type NHE1 with S703A-
NHE1 protein caused noticeable changes in cell 
morphology that were examined in further detail. When 
adherent, fixed cells were visualized under bright-field 
microscopy, wtNHE1, 231koNHE1, SSSA, and 1K3R4E 
cells exhibited the stellate cell morphology typical of the 
mesenchymal parental MDA-MB-231 breast cancer cells 
[27]. In contrast, S703A cells exhibited a more rounded or 
cuboidal epithelial-like phenotype and the majority of cells 
appeared smaller than cells expressing wtNHE1 (Figure 
2a). When cell size (Forward Scatter-Area, FSC-A) versus 
granularity (Side Scatter-Area, SSC-A) was analyzed by 
flow cytometry, S703A cells were significantly smaller 
than wtNHE1 cells (Figure 2b, 2c). SSSA cells were also 
slightly smaller than the wtNHE1, but the difference was 
not considered significant. There was no difference in size 
between wtNHE1, 231koNHE1, and 1K3R4E cells. The 
degree of granularity (a measure of cytosolic complexity) 
did not vary between the cell types.
Effect of NHE1 mutations on the proliferation of 
MDA-MB-231 cells
To investigate the effect of negating NHE1 
activation mediated by p90RSK/14-3-3 (S703A) and 
ERK1/2 (SSSA), versus constitutively activating NHE1 
by blocking exchanger auto-inhibition (1K3R4E), we 
compared the rates of proliferation between mutant NHE1 
cells, cells expressing wild-type NHE1, and 231koNHE1 
cells. As seen in Figure 3a, S703A cells had a significantly 
higher rate of proliferation compared to wtNHE1, 
231koNHE1, and other mutant-containing cells at 24 and 
48 hr. (+P < 0.01, *P < 0.001, N = 3). We then used laser-
scanning cytometry to analyze potential differences in the 
progression of mutant NHE1 and wtNHE1 cells through 
the cell cycle. We quantified the percentage of cells in each 
phase of the cell cycle at a single time point 24 hr. after an 
equal number of cells were plated in serum-supplemented 
media. Here, mean integral fluorescence is proportional to 
DAPI-DNA binding and maximum pixel values indicate 
chromatin concentration [28]. We found that there were 
significantly more S703A cells in the first growth phase G1 
compared to wtNHE1 cells (#P < 0.05, Figure 3b), while 
the estimated duration of the second growth and mitotic 
phases (G2/M) for S703A cells was much shorter than 
in wtNHE1 cells (#P < 0.05, Figure 3c). We also found 
that there were more 1K3R4E cells in G1, but fewer cells 
in G2/M. Similarly, the duration of G1 was longer and 
G2/M was shorter, respectively, in 1K3R4E cells relative 
to wtNHE1 cells (*P < 0.001, Figure 3b, 3c). Progression 
of SSSA cells through the cell cycle was comparable to 
wtNHE1 cells. 
Effect of mutations to NHE1 regulatory regions 
on migratory and invasive capacity of MDA-
MB-231 cells
We examined the effect of mutations to NHE1 
regulatory regions on migration and invasion of cells 
carrying the mutant NHE1 proteins. In S703A-expressing 
breast cancer cells, there was a marked decrease in 
the rates of migration and invasion compared to cells 
expressing wtNHE1 (*P < 0.001, N = 4, Figure 4a and 4b). 
S703A cells were also less migratory than 231koNHE1 
cells, and both these cell types had the lowest invasion 
rates of all the cells studied (+P < 0.01, *P < 0.001, N 
= 4, Figure 4a and 4b). In cells where the ERK1/2-
mediated regulation of NHE1 was disrupted (SSSA), the 
rate of migration over 24 hr. was also reduced relative 
to wtNHE1 cells (+P < 0.01, N = 4, Figure 4a), but there 
was no significant difference in the invasive capacity of 
these cells (Figure 4b). In contrast, rates of migration and 
invasion were significantly higher in 1K3R4E cells where 
NHE1 was rendered constitutively active (*P < 0.001, N 
= 4, Figure 4a and 4b). We hypothesized that 1K3R4E 
cells might be behaving like cells with a higher NHE1 
expression. We therefore examined an MDA-MB-231 
cell line containing both endogenous NHE1 protein and 
exogenous wild-type NHE1 protein (NHE1++). We 
found that these cells, where wild-type NHE1 was over-
expressed, also had increased rates of migration and 
invasion similar to those observed in cells expressing the 
1K3R4E mutant NHE1 protein (Figure 4a and 4b).
Effect of NHE1 regulatory mutations on colony 
and spheroid growth
To investigate the ability of mutant NHE1-
containing MDA-MB-231 cells to form new metastases in 
vitro, we studied anchorage-dependent colony formation 
and anchorage-independent embedded colony growth 
in soft agar and Matrigel™ matrix. Parental MDA-
MB-231 cells are aggressively metastatic; likewise, cells 
expressing wtNHE1 exhibited a high capacity for colony 
growth both on substrate and in soft agar (Figure 5). In 
S703A-expressing cells, where stimulation of NHE1 by 
phosphorylation at Ser703 is prevented, colony formation 
and spheroid growth were markedly reduced (*P < 0.001, 
N = 3, Figure 5a, 5b). S703A cells displayed the least 
colony-forming growth potential of all mutant NHE1-
expressing cell types regardless of anchorage dependency 
in comparison to wtNHE1. Interestingly, anchorage-
dependent colony formation of S703A cells (Figure 
5b.i) was even less than that observed in 231koNHE1 
cells (Figure 9a.ii), but anchorage-independent colony 
formation in soft agar of S703A cells (Figure 5b.ii) was 
comparable to that of 231koNHE1 cells (Figure 9b.ii). 
SSSA cells also had reduced anchorage-dependent colony 
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Figure 3: Cell proliferation and cell cycle analysis of mutant and wild-type NHE1-expressing MDA-MB-231 cells. a. 
Measurement of cell proliferation rates over time. The rate of proliferation of wtNHE1, 231koNHE1, S703A, SSSA and 1K3R4E cells 
was assessed at 0, 24, and 48 hr. by spectrophotometric analysis of the enzymatic reduction of yellow tetrazolium MTT. Data shown are 
representative of mean OD values for each cell type at indicated time points compared to initial OD values at 0 hr. [+P < 0.01; *P < 0.001; 
N = 3]. b. and c. Cell cycle analysis of mutant NHE1 cells relative to wtNHE1 cells. Laser-scanning cytometry was used to quantify changes 
in cell cycle progression over 24 hr. as described in the Materials and Methods. b. Analysis of cell numbers in each phase of the cell cycle 
in wtNHE1, S703A, SSSA and 1K3R4E cells. The percentage of cells in each phase at a single time point (univariate analysis) of the cell 
cycle is calculated from mean integral fluorescence (which is proportional to DAPI-DNA binding) and mean maximum pixel values (which 
indicates chromatin concentration). [#P < 0.05, *P < 0.001 vs. control; N = 3]. c. Duration of cell cycle phases in wtNHE1, S703A, SSSA 
and 1K3R4E cells. The length of time spent in each phase of the cell cycle was estimated using the following equation: TPhase = [TC × 
ln(fPhase+1)]/ln2, where TC is the duration of the cell cycle or population doubling time, and fPhase is the fraction of cells in a particular phase 
of the cell cycle [59]. 
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Figure 4: Rates of migration and invasion of mutant NHE1 cells compared to wild-type NHE1-expressing cells and 
231koNHE1 cells. a. Rate of cell migration in mutant NHE1 cells compared to wild-type NHE1 cells and 231koNHE1 cells. Cell 
migration was assessed using a qualitative wound-healing assay. i, Pictorial representation of migration in wtNHE1, 231koNHE1, S703A, 
SSSA 1K3R4E and NHE1++ cells over time (bright-field microscopy at 10X magnification). ii, Rate of closure of the induced gap at 24 
hr. in cells cultured in complete growth media [#P < 0.05, +P < 0.01, *P < 0.001; N = 4]. b. Rate of cell invasion in wtNHE1, 231koNHE1, 
S703A, SSSA, 1K3R4E and NHE1++ cells over time. Cell invasion was evaluated by quantification of cells traversing through porous 
Matrigel™-coated transwell inserts over 24 hr. by bright-field microscopy (10X magnification). i. Pictorial representation of cell invasion 
(bright-field microscopy at 10X magnification). ii. The number of invading cells per field of mutant NHE1 cells compared to cells expressing 
wtNHE1 and 231koNHE1 cells [*P < 0.001; N = 4].
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Figure 5: Colony formation and spheroid growth of NHE1 mutant cells compared to wtNHE1 cells. Cell colonization 
was assessed by anchorage-dependent and anchorage-independent (in soft agar) colony forming assays and spheroid growth assays in 
Matrigel™ matrix (a and b). a.i., Anchorage-dependent colony formation. Colony growth of wtNHE1, S703A, SSSA, and 1K3R4E cells 
on cell culture-treated plates was used to evaluate anchorage-dependent growth over 2 weeks, after which cells were fixed, permeabilized 
and stained with crystal violet. Images shown represent single colony morphology under bright-field microscopy at 10X magnification 
prior to staining, and the total number of stained colonies per 60 mm plate. a.ii. Anchorage-independent colony formation. As described 
in the Materials and Methods, colony growth of wtNHE1 and mutant NHE1 cells embedded in 0.7% soft-agar in 6-well plates was used 
to evaluate anchorage-independent cell colonization over 6 weeks. Images shown are a representation of the total number of colonies per 
well. a.iii. Spheroid growth in Matrigel™ matrix. wtNHE1 and mutant NHE1 cells were aggregated, embedded, and grown in a suspension 
of 5% Matrigel™ in a 96-well plate to determine their ability to form spheroids. After 7 days, cells grow and develop into one single 
spheroid cell cluster per well. Images shown represent a single spheroid under bright-field microscopy at 2.5X magnification. b. Graphical 
representation of anchorage-dependent and anchorage-independent colony formation and spheroid growth in wtNHE1 and mutant NHE1 
cells. Colonies with >50 cells each for anchorage-dependent growth, and colonies with a diameter of >1 mm for anchorage-independent 
growth, were counted and represented graphically (b.i and b.ii respectively), as was an arbitrary comparison of the area of spheroid growth 
of the different cell types (b.iii) [*P < 0.001; N = 3]. 
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formation though the effect was not as pronounced 
as in S703A cells. Similarly, SSSA-expressing cells 
also exhibited reduced anchorage-independent colony 
formation in soft agar, though again the effect was not 
as obvious as in S703A cells. There was no significant 
effect of the SSSA mutation on spheroid growth in 
Matrigel™ matrix. The 1K3R4E-expressing cells had 
similar anchorage-independent embedded growth in soft 
agar relative to the wtNHE1 cells but had slightly reduced 
anchorage-dependent colony formation. In spheroid 
growth assays, 1K3R4E cells formed significantly larger 
spheroids (*P < 0.001, N = 3, Figure 5a.iii, b.iii). Notably, 
when single colony morphology of anchorage-dependent 
colony growth was more closely examined, the rounded, 
epithelial-like phenotype of S703A cells was conspicuous. 
Whereas wtNHE1, SSSA, and 1K3R4E cells form single 
colonies with indistinct cell-cell connections, the S703A 
cells showed much more robust cell-cell contacts (Figure 
5a.i). 
Effect of mutations to NHE1 on vimentin and 
β-catenin expression
Epithelial-mesenchymal transition (EMT) is 
considered a key developmental process in tumorigenesis, 
wherein epithelial cancers like breast cancer become 
metastatic. We assessed the expression of mesenchymal 
marker vimentin and epithelial marker β-catenin in 
cells expressing mutant NHE1 by western blot analysis 
and laser-scanning cytometry/microscopy. Western blot 
analysis showed that neither vimentin (Figure 6a) nor 
β-catenin (Figure 6b) expression in wtNHE1 or mutant 
NHE1 cells was significantly altered by the presence 
(UNSTIM) or absence of serum (STIM). However, 
vimentin protein expression was significantly decreased 
in S703A cells compared to wtNHE1 cells (+P < 0.01, 
N = 3, Figure 6a.i and 6a.ii). Interestingly, vimentin and 
β-catenin expression in MDA-MB-231 cells where NHE1 
was knocked out (231koNHE1) was comparable to that 
of wtNHE1 cells at both protein and mRNA levels (N 
= 3, Supplementary Figure 1c). In SSSA and 1K3R4E 
cells, assay of vimentin protein expression by western 
blot analysis revealed a reduction in protein expression 
that was not statistically significant. The reduction 
of vimentin expression in S703A cells was also seen 
at the transcriptional level where mRNA expression 
was significantly decreased in these cells compared to 
wtNHE1 cells (#P < 0.05, N = 5, Figure 6a.iii). Expression 
of vimentin mRNA in SSSA and 1K3R4E cells was 
comparable to wtNHE1 cells. We further analyzed 
vimentin expression in mutant NHE1 cells by laser-
scanning cytometry/microscopy. Images show vimentin 
expression (green fluorescence) in S703A, SSSA and 
1K3R4E cells compared to wtNHE1 cells (Figure 6c), 
where mean integral fluorescence is proportional to 
protein expression. When quantified, vimentin expression 
was significantly decreased in all NHE1 mutant breast 
cancer cells (*P < 0.001, N = 3, Figure 6d); however, the 
down-regulation of vimentin observed in S703A cells (+P 
< 0.01, N = 3, Figure 6d) was greater than that of SSSA 
and 1K3R4E cells. Additionally, vimentin also appeared 
to become aggregated in S703A cells, unlike the even 
cytosolic distribution seen in wtNHE1 cells (Figure 6c). 
Expression of β-catenin protein, as determined by western 
blotting (Figure 6b.i and 6b.ii) or laser-scanning cytometry 
(Figure 6e), was unaffected by mutations to NHE1. 
However, on the transcriptional level, gene expression of 
β-catenin was significantly higher in S703A cells (#P < 
0.05, N = 5, Figure 6b.iii). We further examined the mRNA 
expression of other factors involved in EMT: transcription 
factors Twist, Snail, and Slug; matrix metalloproteinases 
MMP2 and MMP9; E-cadherin (epithelial marker) and 
N-cadherin (mesenchymal marker). MMP2 mRNA 
levels decreased in S703A-containing cells, while MMP9 
expression increased. In SSSA cells, mRNA expression of 
Twist, Slug, and E- and N-cadherin are increased, while 
in 231koNHE1 cells, E-cadherin mRNA expression is 
significantly higher (#P < 0.05, +P < 0.01, *P < 0.001, 
N= 5, Supplementary Figure 2). Western blot analyses to 
detect the expression of these EMT markers on the protein 
level were unsuccessful (data not shown); additionally, 
MDA-MB-231 cells do not express E- and N-cadherin 
protein. Because of a lack of expression on the protein 
level, we were unable to draw any conclusions from the 
changes in mRNA expression of these EMT markers in 
relation to mutations to NHE1 regulation.
Effect of BI-D1870 on NHE1 activity and cell 
proliferation in triple-negative breast cancer cells
The S703A mutation on NHE1 prevents the 
phosphorylation of Ser703 by p90RSK, consequently also 
preventing 14-3-3 binding to the phosphorylated Ser703 
residue. We therefore wanted to test the potential effect 
of BI-D1870, a potent and specific inhibitor of p90RSK, on 
Na+/H+ exchange activity in parental MDA-MB-231 cells. 
For comparison, we also tested the effect of BI-D1870 on 
NHE1 activity in two other triple-negative cell lines: the 
tumorigenic, moderately invasive MDA-MB-468 and the 
non-tumorigenic, minimally invasive Hs578T cells. In 
stimulated conditions where NHE1 is activated by serum 
deprivation (0.2% serum), 10 µM BI-D1870 significantly 
decreased relative Na+/H+ exchange in MDA-MB-231 and 
Hs578T cells, but not in MDA-MB-468 cells. This effect 
is not observed in unstimulated cells supplemented with 
10% serum (+P < 0.01, *P < 0.001, N = 6, Figure 7a). 
This concentration of BI-D1870 is not cytotoxic (N = 3, 
Figure 7b) so observed effects are not due to cell death. 
Furthermore, treatment of cells with 5 µM BI-D1870 
only over 48 hr. significantly reduced cell proliferation in 
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Figure 6: Expression of vimentin and β-catenin in wild-type and mutant NHE1-expressing cells. The expression of 
mesenchymal marker vimentin and epithelial marker β-catenin was assessed by western blot, qRT-PCR, (a, b) and laser-scanning cytometry/
microscopy (c-e). a. and b. Western blot and qRT-PCR analysis of vimentin and β-catenin in cell lysates of MDA-MB-231 cells expressing 
wtNHE1, S703A, SSSA, and 1K3R4E. For western blot analysis, cells were cultured in either unstimulated (10% serum in complete media) 
or stimulated (0.2% serum) conditions for 24 hr. prior to lysis. Actin and tubulin were used as loading controls. a.i, Representative western 
blot showing vimentin expression, and a.ii, corresponding quantification of protein expression by densitometry. a.iii, mRNA expression of 
vimentin determined by qRT-PCR. b.i, Representative western blot showing β-catenin expression, and b.ii, corresponding quantification of 
protein expression by densitometry. b.iii, mRNA expression of β-catenin determined by qRT-PCR. Protein expression of vimentin (a) or 
β-catenin (b) expression by western blot was compared with levels in the unstimulated wtNHE1 cell lysates [+P < 0.01, N = 3]. Vimentin 
and β-catenin expression at the transcriptional level (mRNA) was compared to GAPDH [#P < 0.05, N = 5] in unstimulated cells. c. 
Pictorial representation of vimentin fluorescence (green) and DAPI nuclear staining (blue) in fixed, unstimulated wtNHE1, S703A, SSSA, 
and 1K3R4E cells by laser-scanning microscopy at 40X magnification. d. and e. Quantification of vimentin (d) and β-catenin (e) protein 
expression in unstimulated conditions as a measure of mean integral fluorescence [+P < 0.01, *P < 0.001, N = 3].
Oncotarget21101www.impactjournals.com/oncotarget
Figure 7: Effect of BI-D1870 on Na+/H+ exchange, viability, and proliferation in MDA-MB-231, MDA-MB-468, and 
Hs578T cells, compared to 231koNHE1 cells. BI-D1870, a potent p90RSK-specific inhibitor, was tested to evaluate its effects on 
NHE1 exchanger activity. a. Na+/H+ exchange activity in triple-negative breast cancer cells expressing NHE1 compared to NHE1-knockout 
cells. Cells were either stimulated by serum deprivation (0.2% serum, STIM) or not (10% serum, UNSTIM) overnight in the presence or 
absence of 10 µM BI-D1870 prior to measuring NHE1 activity. The rate of Na+/H+ exchange was calculated from the slope of the first 20 
sec. of recovery post-acid load with ammonium chloride and expressed as ΔpHi/sec. ΔpHi/sec values measured for cells treated with BI-
D1870 were normalized to that of the untreated wtNHE1 control values (not shown) for unstimulated and stimulated cells respectively [*P 
< 0.0001, N = 6]. b. Cytotoxicity of BI-D1870 in all cells. Cell viability was determined with MTT assays as described in the Materials 
and Methods. c. Effect of BI-D1870 on cell proliferation. The rate of proliferation of MDA-MB-231, 231koNHE1, MDA-MB-468 and 
Hs578T cells in response to treatment with 5 µM BI-D1870 was assessed at 24 and 48 hr. Data shown are representative of mean rates of 
proliferation for each cell type at indicated time points compared to 0 hr. [*P < 0.001; N = 3].
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MDA-MB-231 cells, but had no effect on the proliferation 
of 231koNHE1, MDA-MB-468, and Hs578T cells (*P < 
0.001, N = 3, Figure 7c).
Effect of BI-D1870 on migration and invasion in 
triple-negative breast cancer cells
We examined the effect of BI-D1870 on migration 
and invasion of MDA-MB-231, 231koNHE1, MDA-
MB-468, and Hs578T cells (Figure 8). In MDA-MB-231 
cells, a significant reduction in the rate of migration was 
observed when cells were treated with either 5 or 10 
µM BI-D1870 over 24 hr. compared to DMSO-treated 
controls, whereas in MDA-MB-468 cells, a marked 
decrease in migration was observed even at 1 µM BI-
D1870 (*P < 0.001, N = 4, Figure 8a). In Hs578T cells, a 
significant inhibition of migration was only observed with 
10 µM BI-D1870 (+P < 0.01, N = 4, Figure 8a). There 
was no effect of BI-D1870 on migration in 231koNHE1 
Figure 8: Effect of BI-D1870 on migration and invasion in MDA-MB-231, MDA-MB-468, and Hs578T cells, compared 
to 231koNHE1 cells. Cell migration was assessed by wound-healing assays (a), and cell invasion was a measure of the number of cells 
invading through Matrigel™-coated transwell inserts (b). a. Effect of BI-D1870 on cell migration. Rate of migration in MDA-MB-231, 
231koNHE1, MDA-MB-468, and Hs578T cells treated with 1, 5 or 10 µM BI-D1870 over 24 hr. [+P < 0.01, *P < 0.001, N = 4]. b. Effect 
of BI-D1870 on cell invasion. b.i, Pictorial representation of invading cells (bright-field microscopy at 10X magnification). b.ii, Rate of 
invasion of MDA-MB-231, 231koNHE1, MDA-MB-468, and Hs578T cells treated with 5 µM BI-D1870 over 24 hr. [*P < 0.001, N = 4].
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cells. Invasion was a measure of cells traversing porous 
transwell inserts coated with Matrigel™ matrix. When 
cells were treated with 5 µM BI-D1870 over 24 hr., the 
number of invading MDA-MB-231 and MDA-MB-468 
cells was reduced by more than 50% compared to DMSO-
treated control cells (*P < 0.001, N = 3, Figure 8b). 
However, treatment with BI-D1870 did not affect the 
minimally invasive 231koNHE1 and Hs578T cells.
Effect of BI-D1870 on colony growth of triple-
negative breast cancer cells in vitro
Clonogenic assays were used to assess anchorage-
dependent colony formation, and 3D colony growth in 
soft agar was used to evaluate anchorage-independent 
colony formation, which mimics the formation of new 
Figure 9: Effect of BI-D1870 on colony growth in MDA-MB-231, MDA-MB-468, and Hs578T cells, compared to 
231koNHE1 cells. Cell colonization was assessed by anchorage-dependent and anchorage-independent (in soft agar) colony forming 
assays. a. Effect of BI-D1870 on anchorage-dependent colonization. a.i, Images shown represent single colony morphology under bright-
field microscopy at 10X magnification, multiple colonies at 2.5X magnification, and the total number of colonies per 60 mm plate after 
staining with crystal violet. 5 µM BI-D1870 was added to cells after seeding either on Day 1 or Day 7. a.ii, Graphical representation of 
anchorage-dependent colony growth of MDA-MB-231, 231koNHE1, MDA-MB-468, and Hs578T cells when 5 µM BI-D1870 was added 
on Day 7 compared to untreated DMSO controls [*P < 0.001, N = 3]. b. Effect of BI-D1870 on anchorage-independent colonization. b.i, 
Images show the number of colonies of MDA-MB-231, 231koNHE1, MDA-MB-468, and Hs578T cells formed as a result of anchorage-
independent 3D growth in soft agar. Cells in soft agar were treated with 10 µM BI-D1870 in complete media every 5 days and colonies 
were counted after 6 weeks. b.ii, Graphical representation of anchorage-independent soft agar colony growth of cells in the presence of 10 
mM BI-D1870 compared to untreated DMSO controls [*P < 0.001, N = 5].
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metastases in vitro. In clonogenic assays, MDA-MB-231, 
231koNHE1, MDA-MB-468 and Hs578T cells were 
treated with 5 µM BI-D1870 or DMSO in complete 
growth media over 14 days. When BI-D1870 was added 
on Day 1 after cells were seeded, no anchorage-dependent 
colony formation was observed in any of the cell types 
(Figure 9a.i). However, when BI-D1870 was added on 
Day 7, after initial cell colonies had established, no further 
colony growth was observed (of 50 cells or greater per 
colony) with MDA-MB-231 and MDA-MB-468 cells 
compared to DMSO controls (*P < 0.001, N = 3, Figure 
9a.ii). In soft agar assays, 10 µM BI-D1870 was added to 
complete media to assess anchorage-independent colony 
growth (Figure 9b). Here, p90RSK inhibition by BI-D1870 
decreases anchorage-independent colony growth over 6 
weeks in MDA-MB-231 cells and MDA-MB-468 cells 
(*P < 0.001, N = 5, Figure 9b.i and 9b.ii). No effect of BI-
D1870 was seen in anchorage-dependent or -independent 
colony formation of 231koNHE1 and Hs578T cells. 
DISCUSSION
Triple-negative breast cancer remains enormously 
problematic for treatment, with high recurrence rates 
that show limited response to chemotherapy [1, 2]. 
Dysregulated pH homeostasis in these tumor cells plays 
an important role in facilitating cancer progression and 
metastasis. It is the perturbed functionality of the Na+/
H+ exchanger NHE1 that is key in the maintenance 
of the alkaline intracellular pH of tumor cells and the 
acidic extracellular pH of the tumor microenvironment. 
Activation of NHE1 occurs through a rightward shift 
in the pH vs. activity curve resulting in higher NHE1 
activity at a given intracellular pH [8, 29]. This excessive 
NHE1 activity promotes extracellular matrix proteolysis 
and cell invasion [30]. We have previously reported 
that inhibiting NHE1 activity increases the efficacy of 
low-dose paclitaxel chemotherapy in TNBC cells, and 
MDA-MB-231 cells lacking NHE1 expression are unable 
to establish in vivo xenograft tumors in mice [9]. In the 
present study, we further investigated whether disrupting 
NHE1 regulation would yield novel insights with which to 
combat and target metastatic TNBC. We used the MDA-
MB-231 TNBC cell model and replaced endogenous 
NHE1 with wild-type or mutant NHE1 protein expressing 
three different regulatory mutations. We disrupted NHE1 
regulation mediated through Ser703 via p90RSK/14-3-3 
(S703A). p90RSK, a signal kinase downstream of ERK1/2, 
activates NHE1 at Ser703 in response to serum and growth 
factors [31, 32]. We also examined the effect of mutation 
of ERK1/2 phosphorylation sites at Ser766, Ser770 and Ser771 
(SSSA). ERK1/2 directly phosphorylates NHE1 at sites 
including Ser766, Ser770 and Ser771, in response to sustained 
intracellular acidosis [22, 33]. Finally, we examined 
the effect of activation of the NHE1 protein through 
mutation of the high-affinity calmodulin-binding site of 
NHE1 (1K3R4E). The 1K3R4E mutation also interferes 
with the auto-inhibitory domain of NHE1, resulting in a 
constitutively active exchanger [34].
Initially, we characterized the effect of the three 
mutations on NHE1 expression and activity. We tested 
the effect of serum deprivation on activity of the protein 
since, in breast cancer cells, serum deprivation activates 
the Na+/H+ exchanger [6, 26]. In MDA-MB-231 cells, 
preventing the phosphorylation of key residues on NHE1 
by ERK1/2 (SSSA) or p90RSK (S703A) prevented NHE1 
activation by serum withdrawal (Figure 1b). p90RSK-
mediated activation of NHE1 by phosphorylation at 
Ser703 is observed in multiple cell types [18, 19]. 14-3-3 
binds to the phosphorylated Ser703 residue and prevents 
its dephosphorylation, which is key in the growth factor-
mediated activation of NHE1 in response to serum. 
Mutating Ser703 to non-phosphorylatable alanine abolishes 
this interaction in fibroblasts [20] and lowers basal NHE1 
activity in CHO cells, but not in cardiomyocytes [35]. Our 
results demonstrate that Ser703 also plays an important role 
in NHE1 regulation in TNBC cells though basal exchanger 
activity was not affected. The SSSA-NHE1 protein was 
also not activated by serum withdrawal and its basal 
activity was similarly unaffected. However, this was not 
reflected in many other phenotypic effector functions in 
MDA-MB-231 cells expressing this mutation to NHE1. 
The activity of the 1K3R4E mutant NHE1 protein was also 
unaltered by serum withdrawal. This may have been due to 
the constitutive activation of the 1K3R4E-NHE1 protein. 
We found that the exchanger activity of the 1K3R4E cells 
was elevated, with it being significantly higher at acidic 
intracellular pH, akin to exchanger activity in cells over-
expressing NHE1 (NHE1++). These results were similar 
to those reported earlier in which we confirmed that other 
1K3R4E-containing cells had elevated NHE1 activity 
[36]. 
Analysis of cell proliferation and cell cycle 
progression indicated that there were significant 
differences in S703A and 1K3R4E cells, relative to 
cells expressing wild-type NHE1. S703A cells showed 
a significant increase in proliferation, which was 
accompanied by an increase in the proportion of cells 
in the G1 phase of the cell cycle. The reason for this 
increase in proliferation is not known at this time but a 
similar trend was also seen in lung fibroblasts harboring 
the same S703A mutation to NHE1 [37]. We hypothesize 
that cell growth and proliferation may be under a different 
regulatory control than other effector functions, like 
motility and invasion, which are adversely affected by this 
mutation to NHE1 as discussed below. The 1K3R4E cells 
also showed alterations in phases of the cell cycle. We 
found significantly more 1K3R4E cells in G1, the growth 
phase associated with increased cell size and biosynthesis 
activities, and less cells in G2/M, the growth phase leading 
up to mitotic division. Additionally, the duration of the 
G2/M phase was shorter and G1 was longer, suggesting 
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that these cells were growing but not dividing (G0 phase). 
Our results confirm that mutation of these two regulatory 
regions influence growth of MDA-MB-231 TNBC cells. 
The most distinctive change brought about by a 
mutation to NHE1 was that induced by the replacement 
of serine 703 with a non-phosphorylatable alanine 
(S703A). This mutation caused cells to exhibit a more 
epithelial-like morphology compared to the mesenchymal 
morphology of cells expressing wild-type NHE1. This 
finding is significant since cancer-associated epithelial-
mesenchymal transition (EMT) is reversible and thought 
to lend plasticity to tumor cell morphology, allowing 
for migration and invasion of cancer cells out of the 
primary tumor and into the bloodstream. The reverse 
process of mesenchymal-epithelial transition (MET) 
is considered to be equally important in establishing 
secondary metastases in organs distant from the tissue of 
origin [38]. Evidence for the change in phenotype caused 
by the S703A mutation was gained by examining cell 
morphology and the cellular expression of mesenchymal 
marker vimentin. MDA-MB-231 cells normally exhibit 
a stellate phenotype with an elongated cell body and 
multiple invasive processes typical of mesenchymal cells 
[27]. In contrast, S703A-expressing cells were smaller, 
and more rounded and epithelial-like than wtNHE1 
cells. This change in S703A cell morphology correlated 
with a dramatic down-regulation of vimentin, both at 
protein and transcriptional levels. Additionally, vimentin 
distribution became compacted in S703A cells, forming 
aggregates close to cell nuclei, compared to its uniform 
cytoplasmic distribution in wtNHE1 cells. While some 
decrease in vimentin expression was observed in SSSA 
and 1K3R4E cells, these reductions were less and there 
was no redistribution of vimentin. Additionally mRNA 
and total protein levels were unchanged in these cells. 
Vimentin is a type III cytoskeletal intermediate filament 
protein and its expression determines cell shape, adhesion, 
and motility. The changes we found in vimentin were 
comparable to changes in cell morphology and vimentin 
expression reported by others in bladder carcinoma cells 
[39]. This pattern of vimentin expression with associated 
morphological changes is also seen in another cell type: 
the non-invasive, hormone receptor-positive MCF-7 
breast cancer cells. When MCF-7 cells were microinjected 
with vimentin or transfected with vimentin cDNA, these 
rounded, epithelial-like cells adopted elongated shapes 
similar to those of mesenchymal cells. Conversely, 
knocking-down vimentin expression in mesenchymal 
MDA-MB-231 cells resulted in an epithelial-like 
morphology and disrupted the structural integrity of the 
remaining vimentin present, causing the formation of 
small clusters of disorganized filaments close to nuclei 
[40]. This is strikingly similar to what we observed in 
S703A cells (Figure 6c). Another more recent study 
also demonstrated that expressing vimentin in MCF-7 
cells increased cell motility and directional migration, 
while knocking down vimentin in MDA-MB-231 
cells decreased rates of migration. More significantly, 
loss of vimentin expression in these cells also caused 
cytoskeletal reorganization, and reduced focal adhesions, 
all of which negatively impacted cell motility [41]. We 
observed similar decreases in migration, invasion, and 
colony growth of S703A cells. Overall, the effects of 
expressing the S703A-NHE1 mutant in MDA-MB-231 
cells correlate well with the published effects of loss of 
vimentin expression on cell phenotype. We also observed 
reduced vimentin expression in SSSA and 1K3R4E cells 
when stained with anti-vimentin antibody (Figure 6d), 
but not to the same extent. Additionally, expression of 
mRNA and total protein of vimentin in both these NHE1 
mutants was not significantly different from wtNHE-
expressing cells, whereas S703A cells showed a significant 
loss of vimentin at both the protein and transcriptional 
levels. Moreover, SSSA and 1K3R4E cells did not lose 
the mesenchymal morphology associated with wtNHE1 
cells; this was only observed in S703A cells. Serine 
703 on NHE1 is the phosphorylation site for p90RSK, 
where 14-3-3 binds to phosphoSer703 and prevents its 
dephosphorylation. Interestingly, 14-3-3 also plays a 
key role in the dephosphorylation and disaggregation of 
vimentin by binding to phosphovimentin [42]. We have 
observed a strong association between 14-3-3 and NHE1 
in MDA-MB-231 cells by mass spectrometric (MS) 
analysis and co-immunoprecipitation (unpublished data). 
The interaction between NHE1 and vimentin, however, 
was weaker and fell just under the threshold limits for MS 
analysis. This raises the intriguing possibility that NHE1 
could be tethered to cytoskeletal vimentin intermediate 
filaments via its association with 14-3-3 at Ser703. This 
would then explain why vimentin distribution is so 
markedly different in S703A cells, where the mutation to 
NHE1 prevents binding of 14-3-3. It is worthwhile to note 
that NHE1 is also tethered to the actin cytoskeleton via 
its association with actin-binding proteins ezrin, radixin, 
and moesin (ERM), which directly bind NHE1 in the 
region spanning aa 552-560. Mutations to this region 
of the exchanger resulted in irregular cell shape and 
disorganization of the cortical cytoskeleton of cells that 
was independent of ion exchange [43]. Here, we present 
the first evidence that disruption of NHE1 regulation 
mediated by p90RSK and, consequently, 14-3-3, affects 
the expression and cytosolic organization of vimentin 
intermediate filaments, enough to significantly alter cell 
morphology and potentially result in mesenchymal-
epithelial transition (MET). Surprisingly, the complete 
knockout of NHE1 did not result in an alteration of cell 
morphology. The reason for this is unclear at this time; 
however, it may be that some part of NHE1 activity is 
necessary for this transition to occur. 
To further examine what happens when p90RSK-
mediated activation of NHE1 in triple-negative breast 
cancer cells is interrupted, we studied the effect of BI-
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D1870 on metastatic potential. BI-D1870 is a potent and 
specific inhibitor of all RSK isoforms. RSK inhibition by 
BI-D1870 and other small-molecule p90RSK inhibitors has 
been reported to significantly decrease growth of TNBC 
cells [44, 45]. Here, we demonstrated that BI-D1870 not 
only caused a significant decrease in anchorage-dependent 
and -independent colony growth similar to that seen in 
the colony growth of S703A cells, but also dramatically 
decreased the rates of migration and invasion of highly 
invasive MDA-MB-231, and moderately invasive MDA-
MB-468 TNBC cells. BI-D1870 was only minimally 
effective in the lowly invasive Hs578T TNBC cells. This 
could be because BI-D1870 also inhibited NHE1 activity 
in MDA-MB-231 cells and, to a lesser extent, in Hs578T 
cells. Both are of the claudin-low, basal B subtype of 
TNBC. However, exchanger activity of MDA-MB-468 
cells, of the basal A TNBC subtype, was not affected. 
Surprisingly, treatment with BI-D1870 appeared to 
increase the basal NHE1 activity of unstimulated MDA-
MB-231 cells; however, the reason for this is not known.
SSSA cells also displayed a lower metastatic 
capacity, though not to the same extent as S703A cells. 
Rates of colony formation were significantly reduced 
in S703A and SSSA cells compared to wtNHE1 and 
1K3R4E cells. Anchorage-dependent colony formation is 
generally indicative of adherent cell growth, while growth 
in soft agar is a characteristic of anchorage-independent 
cells that correlates strongly with a more invasive and 
metastatic cell phenotype [46]. Parental MDA-MB-231 
cells are an adherent cell line, so exhibiting anchorage-
dependent growth despite having an invasive phenotype 
is not surprising. All three mutations, however, decreased 
anchorage-dependent colony formation relative to 
wtNHE1 cells. A more robust conclusion on anchorage-
dependency of mutant NHE1 cells can be drawn from 
their growth in soft agar. Both wtNHE1 and 1K3R4E 
cells were capable of establishing colonies in soft agar, 
larger and more numerous than those seen with either 
S703A or SSSA cells, suggesting that these cells have a 
higher metastatic potential. Lower rates of migration were 
also observed in SSSA cells compared to wtNHE1 cells; 
however, invasion and spheroid growth were not affected. 
Invasion and spheroid growth in extracellular matrix are 
more indicative of in vivo conditions, which suggest that 
the effects we saw on migration and colony formation 
are less significant in SSSA cells. The SSSA mutation 
in NHE1 is a change in serine residues 766, 770, and 
771 to non-phosphorylatable alanine residues. We have 
previously shown that one or more of these residues are 
phosphorylated directly by ERK1/2 and that this affects 
the response to acute intracellular acid load in various cell 
types [22, 33, 47]. The ERK1/2 regulatory pathway and 
amino acid residues 766, 770, and 771, while still having 
significant effects on the cell’s invasive capacity, appears 
to be of less importance relative to Ser703 and the NHE1 
auto-inhibitory and calmodulin-binding domain. 
1K3R4E-expressing cells exhibited some very 
significant and interesting changes in behavior, though 
other traits were not affected by this mutation to NHE1. 
Cell size, complexity, and the rate of proliferation were 
not different compared to wtNHE1 cells. Additionally, the 
amount of anchorage-dependent or -independent colony 
formation did not increase. However, other parameters 
that can affect the potential metastatic behavior of cells 
in vivo changed dramatically. For example, the rate of 
cell migration and invasion through Matrigel™-coated 
transwell inserts was increased. In order to better evaluate 
the metastatic potential of these cells, embedded cell 
growth in Engelbreth-Holm-Swarm mouse sarcoma 
cell matrix (Matrigel™) was used to simulate the 
complex, dynamic interplay between cancer cells and the 
extracellular matrix in vitro. This allows for cell growth 
in three dimensions and the development of spheroid cell 
masses more similar to the formation of new metastases 
in vivo [27, 48]. The activation of NHE1 in the 1K3R4E 
cells conferred distinctly larger spheroid growth compared 
to the wild-type NHE1 protein. Taken together, our data 
demonstrates, for the first time, that up-regulation of 
exchanger activity associated with the high affinity 
calmodulin-binding site is a critical determinant of the 
metastatic potential of TNBC cells. 
We recently reviewed the importance of intracellular 
ions and NHE1-mediated dysregulation of H+ flux in 
driving cancer progression [49]. In cancer cells, increased 
intracellular Na+ is thought to promote invasiveness [50], 
while changes in intracellular K+ can be correlated with 
altered rates of proliferation and migration [51]. However, 
only cytosolic Ca2+ signaling has been implicated in 
inducing epithelial-mesenchymal transition in breast 
cancer cells [52]. Increased intracellular Na+ can occur 
from elevated cellular alkalinization by NHE1; however, 
this was not detected in the present study, likely due to 
the activity of sodium-extruding proteins such as Na+/K+-
ATPase. In an analysis of primary patient tumor proteins, 
we reported a 1.5 to 2-fold increase in NHE1 mRNA 
expression in cancers of the breast, particularly of the 
invasive subtypes, a correlation that was not seen with 
sodium-bicarbonate transporters or voltage-gated sodium 
channels [49]. We did not find differences in levels of 
intracellular Na+ or Ca2+ between the mutant and wtNHE1 
cells; however, S703A cells had significantly elevated 
intracellular K+ levels than wtNHE1 cells (Supplementary 
Figure 1b). While the reasons for this are not clear, altered 
K+ channel conductance and K+ channel expression can 
affect cell proliferation [51]. Whether altered K+ channel 
activity plays a role in the increased proliferation rates of 
S703A cells is not known at this time. 
In this study, our goal was to investigate the 
underlying regulatory mechanisms that instigate the 
dysregulation of NHE1 activity. We examined three 
regulatory regions of the NHE1 protein: Ser703, the 
group of Ser766, Ser770 and Ser771, and the high-affinity 
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calmodulin-binding site of NHE1 located at amino acids 
636-659 [12]. The group of phosphorylatable amino acids 
on NHE1 at Ser766, Ser770 and Ser771 has a significant 
but more minor role in affecting MDA-MB-231 cell 
invasiveness. In contrast, the high-affinity calmodulin-
binding site of NHE1 and Ser703 have critical roles in 
regulating metastatic behavior. Ser703, in particular, 
could play a role in maintaining metastatic potential in 
these cells. The fact that chemical inhibition of p90RSK 
by BI-D1870 adversely affects the metastatic potential 
of otherwise invasive TNBC cells lends credence to this 
hypothesis. We suggest that Ser703 on the NHE1 C-terminal 
may also be an important “phosphorylation switch” 
regulating EMT in TNBC cells. Phosphorylation of Ser703 
by p90RSK, and maintenance of its phosphorylation state 
by the binding of 14-3-3 regulatory proteins, may then 
be involved in maintaining the NHE1 signal scaffold 
that sustains the invasive mesenchymal morphology of 
MDA-MB-231 cells via its interaction with vimentin 
intermediate filaments. Dephosphorylation of Ser703 (or 
its mutation to a non-phosphorylatable residue) could 
thus revert these cells to an epithelial-like phenotype 
where the metastatic potential inherent to parental cells 
expressing endogenous wild-type NHE1 is substantially 
diminished. The Ser703 site on NHE1 may thus be a useful 
and promising new target for treatment of triple-negative 
breast cancer.
MATERIALS AND METHODS
Cell lines and culture conditions
MDA-MB-231 cells, including all mutants made 
in this parental cell line, and MDA-MB-468 cells, were 
cultured in high-glucose modified DMEM (HyClone) 
supplemented with 10% fetal calf serum (HyClone), 10 
mM HEPES, and 1000 units/ml penicillin/streptomycin 
(Gibco) under standard culture conditions (5% CO2, 37°C 
and high humidity). Hs578T cells were grown in similar 
culture media additionally supplemented with 0.01 mg/
ml bovine insulin but without penicillin/streptomycin. 
Starvation media contained only 0.2% serum but was 
otherwise identical in composition. NHE1 mutant cell 
lines were grown in the presence of 400 mg/mL G418 
(Geneticin Sulfate, Santa Cruz). All parental cell lines 
were authenticated by DNA analysis (DDC Medical, Ohio) 
and showed >95% homology to the ATCC STR profile. 
BI-D1870 (2-(3,5-Difluoro-4-hydroxyphenylamino)-8-
isopentyl-5,7-dimethyl-7,8- dihydropteridin-6(5H)-one; 
Axon MEDCHEM, Netherlands), a potent and specific 
inhibitor of p90RSK, was prepared in DMSO and used at 
the indicated concentrations.
Generation of NHE1-knockout and NHE1-mutant 
MDA-MB-231 cells
In MDA-MB-231 breast cancer cells, endogenous 
NHE1 was excised using CompoZr® Zinc Finger 
Nucleases (Sigma-Aldrich) specifically targeted to 
knockout the human NHE1 gene SLC9A1, according to the 
manufacturers’ protocols. Knockout cells were screened 
and selected as previously described [9]. NHE1-knockout 
MDA-MB-231 cells were used to make stable cell lines 
containing wild-type and mutant NHE1 proteins. The 
pYN4+ plasmid [53], which contains cDNA for the full-
length wild-type human NHE1 protein (wtNHE1), was 
stably introduced into the NHE1-knockout cells by Amaxa 
nucleofection (Lonza). The plasmid has a hemagglutinin 
(HA) tag that does not affect exchanger activity [54]. Site-
specific mutagenesis was used on the pYN4+ plasmid 
to generate NHE1 mutants as described earlier [55]. To 
determine the effect of various phosphorylation sites 
on NHE1 activity, one site was individually targeted 
(Ser703), and three other sites were targeted in tandem 
(Ser766, Ser770, Ser771), where serine residues were altered 
to alanine, a non-phosphorylatable amino acid residue, to 
generate the stable S703A and SSSA mutants respectively 
[22]. Additionally, four positively-charged residues 
were targeted together (Lys641, Arg643, Arg645, Arg647) and 
replaced with negatively-charged glutamic acid residues 
to generate the stable 1K3R4E mutant as described 
earlier. We have previously shown that this precise 
mutation results in a hyperactive NHE1 protein [13]. For 
comparative purposes, we also generated an NHE1 over-
expression mutant (NHE1++) where the pYN4+ plasmid 
(wtNHE1) was introduced into the parental MDA-MB-231 
cells that also expressed endogenous NHE1 protein. 
Na+/H+ exchanger activity: Measurement of ion 
concentration and proton (H+) flux
Intracellular pH
Intracellular pH (pHi) was measured via 
fluorescence using the pH indicator dye, BCECF 
(2’,7’-bis(carboxyethyl)-5(6)-carboxyfluorescerin-
acetoxymethyl ester). Briefly, cells were grown to 80% 
confluence on rectangular glass coverslips in 35 mm 
dishes in complete media, and either serum-starved or not 
for 24 hr. post-attachment. BCECF-AM, a cell permeable 
dye, was added to cells for 20 minutes at 37°C. During 
this time, cytosolic esterases cleave the AM ester, allowing 
fluorescent BCECF to become charged, polarized, and cell 
impermeable; intracellular BCECF fluorescence is thus a 
measure of pHi. Cells were then acidified by addition of 
ammonium chloride (50 mM, 3 min) followed by its rapid 
withdrawal [54]. For recovery post-acid load, cells were 
perfused with Na+-free and then Na+-containing buffers. 
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After measurement of activity, pHi was calibrated using 
buffer containing nigericin and high K+ at pH 6, 7 and 8. 
The ratio of BCECF fluorescence with excitation at 440 
nm and 502 nm, and emission at 528 nm, was recorded 
using a PTI Deltascan Illumination System (Photon 
Technology International, New Jersey, USA). Buffering 
capacity was calculated and was similar across all cell 
types (data not shown). NHE1 activity was calculated 
from the slope of the first 20 sec of recovery of pHi from 
acidification (ΔpHi/sec). Cells were either stimulated 
(0.2% serum) overnight prior to measuring NHE1 
activity, or supplemented with 10% serum (unstimulated). 
In experiments testing the effect of BI-D1870 on NHE1 
activity, cells were additionally treated with 10 µM BI-
D1870 overnight. Data were normalized to the wild-type 
(wtNHE1) control to show relative Na+/H+ exchange 
activity between cell types.
Proton flux
Proton affinity was a measure of H+ flux (JH
+). H+ 
flux was calculated as the product of the rate of change 
of pHi over time (ΔpHi/sec) and the buffering capacity of 
cells (B mmol • 1-1 • pH unit-1) as previously described 
[56]. Buffering capacity was determined by varying 
ammonium chloride concentrations (10 mM, 30 mM, or 
50 mM) and measuring intracellular pH and calculating 
buffering as described earlier [56].
Ion concentration
Intracellular and extracellular Na+, K+, Mg2+, and 
Ca2+ concentrations of wtNHE1 and NHE1-mutant cells 
were determined using inductively coupled plasma optical 
emission spectroscopy (ICP-OES, iCAP 6000, Thermo 
Scientific, Canada). Cells were seeded in a 12-well 
plate, grown to confluence, and either stimulated (0.2% 
serum) or unstimulated (10% serum) overnight. Cells 
were thoroughly washed in sodium- and potassium-free 
buffer and then lysed with 0.5 mL of 0.1% Triton X-100 
and 0.2% nitric acid overnight at 4°C with agitation, prior 
to sonication for 1 min as previously described [57]. 
Samples and buffer blanks were then diluted 100 times 
in ultrapure deionized water and filtered to remove any 
particulate matter. For the ICP-OES analysis, the digestion 
method used was EPA 3051, with nitric acid at a ratio of 
5 mL HNO3 to 20 mL ultrapure deionized water, using the 




Cell size versus granularity was evaluated using 
flow cytometry on live cells. Briefly, adherent cells were 
allowed to attach to 6-well plates overnight and then 
trypsinized. Cells were washed with phosphate-buffered 
saline (PBS, HyClone) supplemented with 1% bovine 
serum albumin and filtered to reduce cell aggregation 
prior to analysis by flow cytometry (BD Accuri C6, 
BD Biosciences, US). Dot plots show side scatter area 
(SSC-A), a measure of granularity, plotted against forward 
scatter area (FSC-A), a measure of cell size. Histograms 
show FSC-A for each mutant cell line (grey) compared 
to wtNHE1 cells (black). Cells were gated to eliminate 
dead cells and doublets; all dot plots and histograms were 
similarly gated. 50,000 events (cells) were recorded for 
each experiment. 
Microscopy
Cells were plated on 4-chambered glass slides 
(Falcon) and allowed to attach overnight in complete 
growth media before fixing with ice-cold 100% 
methanol for 15 min at -20°C. Nuclei were stained with 
Hoechst33342 (NucBlue® Fixed Cell ReadyProbes 
reagent, Life Technologies) at room temperature for 5 min 
and cells were visualized with an EVOS FL Cell Imaging 
System (Life Technologies). Images show cells under 
bright-field overlaid with Hoechst33342 fluorescence 
(excitation 360 nm, emission 460 nm) to show nuclear 
localization using a magnification of 20X. Scale bars 
represent 50 μm.
Proliferation and cytotoxicity
Cell proliferation (net growth) and cytotoxicity 
of BI-D1870 was measured as previously described [9]. 
Briefly, cells were seeded into 96-well plates at a density 
of 1 x 104 cells/well for 0 to 48 hr. prior to adding MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide, Sigma] at a final concentration of 0.5 mg/mL. 
To assess cytotoxicity over 24 hr., serial dilutions of 
BI-D1870 were used with concentrations ranging from 
0.0001 to 100 µM. To test the effect of BI-D1870 on 
proliferation, cells were treated with 5 µM of the drug 
over 48 hr. Colorimetric changes were used to assess the 
rate of proliferation at 0, 24, and 48 hr., measuring the 
reduction of yellow tetrazolium MTT to purple formazan 
by metabolically active cells. Cell proliferation over time 
is directly proportional to OD values. A BioTek Synergy 
MX microplate reader (BioTek Instruments Inc.) was 
used to measure absorbance at 570 nm with background 
subtracted at a reference wavelength of 630 nm. Data were 
analyzed with BioTek Gen5 software and are shown as an 
increase in the rate of cell proliferation over time.
Cell cycle analysis and expression of epithelial-
mesenchymal transition (EMT) markers
Cell cycle changes and expression of vimentin 
(mesenchymal marker) and β-catenin (epithelial marker) 
were analyzed using a laser-scanning cytometer (LSC), the 
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iCys Research Imaging Cytometer (CompuCyte/Thorlabs, 
US). Data and image acquisition and analysis was done 
using iCys 3.4 Cytometric Analysis Software. For LSC, 
cells were plated at a density of 8000 cells per well in 100 
uL of complete growth media in a black 96-well optical 
clear-bottom plate (Greiner) overnight at 37°C. Cells were 
then fixed by adding 8% paraformaldehyde in a 1:1 volume 
ratio directly to the media in the wells for 15 min. at room 
temperature. Fixative media was removed and cells were 
washed with 200 uL of phosphate-buffered saline three 
times prior to permeabilization with 0.1% Triton X-100 
in PBS for 10 mins. Cells were washed three times in 
PBS before adding blocking buffer (1% bovine serum 
albumin in PBS-Tween) for 45 min. Cells were incubated 
with primary antibodies against vimentin (Santa Cruz 
Biotechnologies) or β-catenin (Cell Signaling Technology) 
in blocking buffer for 1 hr. at room temperature, and then 
washed three times with PBS. Alexa488- or Alexa594-
conjugated secondary antibodies (Invitrogen) were added 
to cells for 1 hr. before washing with PBS. To determine 
progression of cells through the cell cycle, DNA-specific 
fluorochrome DAPI (4’,6’-diamidino-2-phenylindole; 
300 ng/ml in PBS) was added to wells prior to placing 
plate on computer-controlled stage for analysis by LSC 
overnight. Laser-scanning microscopy images were 
obtained at 40X magnification, for a total of 16 fields/
well. Field images were automatically generated into a 
composite image of the entire well. For protein expression, 
the following parameters were measured for each pre-
determined contoured cell event: Area, physical area 
(mm2) of the contoured cell; Integral Fluorescence, total 
fluorescence (all pixels) in contoured area; and Maximum 
Pixel, fluorescence of brightest pixel in contoured area, 
as previously described [58]. Mean integral fluorescence 
was used to determine vimentin or β-catenin expression 
in mutant-NHE1 compared to wild-type NHE1-expressing 
cells. For cell cycle analysis, integral fluorescence is 
proportional to DAPI-DNA binding and maximum pixel 
values indicate chromatin concentration [28]; these values 
were used to determine percentage of cells in each phase 
of the cell cycle in a univariate analysis. While this single 
time point measurement does not provide information on 
cell cycle kinetics, the duration of each phase of the cell 
cycle was estimated with the following equation: TPhase = 
[TC × ln(fPhase+1)]/ln2, where the duration of the cell cycle 
or population doubling time (TC) for MDA-MB-231 cells 
is approximately 38 hr. (ATCC), and fPhase is the fraction 
of cells in a particular phase of the cell cycle [59]. For 
expression and cell cycle experiments, statistical tables 
for each parameter were generated by iCys software 
and exported for further analysis. Images shown are 
representative of three independent experiments, done 
with 3 to 6 replicates each. Cumulative data from all 
experiments were used to quantify expression and cell 
cycle analysis.
Quantitative real time-PCR (qRT-PCR)
RNA was extracted from cells using the RNeasy 
Minikit (Qiagen) according to the manufacturer’s 
protocols. Total RNA (1 μg) was reversed transcribed to 
cDNA using iScript RT Supermix (BioRad). Quantitative 
RT-PCR was performed using the iQ SYBR Green 
Supermix (BioRad) in a Rotor-Gene RG3000 (Corbett 
Research) cycler, with 40 cycles per sample. Cycling 
temperatures were as follows: denaturing, 95°C; 
annealing, 53°C; and extending, 72°C. The primers used 
are listed in Supplementary Table 1. Differences in gene 
expression are presented as fold changes normalized 
to GAPDH expression. Cumulative data from five 
independent experiments are shown.
Western blotting
Confluent whole cells were lysed to generate total 
protein for separation by 8-10% SDS polyacrylamide 
gels, transferred onto nitrocellulose membranes, and 
analyzed with antibodies against: NHE1 (BD Transduction 
Laboratories), vimentin (Santa Cruz Biotechnologies), or 
β-catenin (Cell Signaling Technology). β-tubulin (Sigma) 
or actin antibodies (Santa Cruz Biotechnologies) were 
used as a loading control. Densitometry using the program 
Image J (ImageJ 1.48v software, National Institutes of 
Health, Bethesda, MD) was used to quantify expression 
of the protein of interest versus the loading control. 
Migration and invasion
Rates of cell migration (percent (%) gap closure 
in wound-healing assays over 24 hr.) and invasion (the 
number of cells traversing through Matrigel™-coated 
transwell inserts (8 µm pore size) over 24 hr.) were 
determined as previously described [9]. To assess the 
effect of BI-D1870 on migration (at concentrations of 1, 5 
and 10 µM) and invasion (5 µM), cells were treated with 
drug for the duration of the assay (24 hr.).
Colony and spheroid growth assays
Anchorage-dependent colony-forming assays
For anchorage-dependent colony-forming assays 
we used 60 mm polystyrene dishes that had been coated 
by the manufacturer to introduce a hydrophilic standard 
growth surface (Sarstedt, Numbrecht, Germany). To 
quantify anchorage-dependent colony growth, cells were 
seeded in the 60 mm dishes at a density of 500 cells per 
dish in complete growth media under standard culture 
conditions [60]. To test the effect of p90RSK inhibition, 5 
µM BI-D1870 in DMSO was added to cultures dishes for 
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the duration of the assay; an equal volume of DMSO alone 
was added to otherwise untreated controls. After 14 days, 
colonies were fixed in ice-cold methanol, stained with 
crystal violet, washed, and left to air-dry. Colonies (>50 
cells/colony) were imaged and counted, and the number 
of mutant colonies was normalized to, and presented as, 
a percentage of the number of wtNHE1 colonies formed. 
Anchorage-independent colony-forming assays
Anchorage-independent growth was assessed 
using colony-forming assays in DNA-grade soft agar 
(Thermo Scientific) as described previously [61]. Agar 
was dissolved in complete growth media and 6-well 
plates were coated with a 0.5% bottom agar layer. 1 × 105 
cells per well were suspended in a 0.7% top agar layer. 
Complete growth media supplemented with 20% fetal 
calf serum was added to wells and changed every 3-5 
days for 4-6 weeks. In BI-D1870 experiments, growth 
media contained 5 µM BI-D1870 in DMSO; an equal 
volume of DMSO alone was added to untreated controls. 
Colonies >1 mm diameter per well were counted. Data are 
a representation of three independent experiments done in 
triplicate.
Spheroid growth
A modified version of the protocol described 
previously [62] was used to study the formation of matrix-
embedded single spheroids in 3D culture. Briefly, round-
bottom 96-well plates were coated with 1.5% DNA-grade 
agarose (Thermo Scientific) in serum-free, phenol red-
free DMEM (50 mL per well). Agarose was allowed to 
set at room temperature before wells were seeded with 
10,000 cells in phenol red-free complete growth media. 
To induce cell aggregation, plates were centrifuged at 
1000 rpm for 15 min. prior to adding 50 mL of a 10% 
Engelbreth-Holm-Swarm mouse sarcoma cell matrix 
solution with an initial protein concentration of 8.1 mg/mL 
(Matrigel™, BD Biosciences). Spheroids were cultured in 
the resulting 5% Matrigel™-growth media suspension for 
7 days in standard culture conditions. Arbitrary spheroid 
area measurements were obtained with Image Pro Plus 
software using a Leica DM IRB microscope (at 2.5X 
magnification). 
Statistical analysis
All data shown are a representation of 3 or more 
independent experiments done with 3 to 8 replicates each, 
and are expressed as means ± SEM. GraphPad Prism 5.0 
(GraphPad Software, CA, US) was used for statistical 
analysis, which was done using the two-way analysis of 
variance (ANOVA) to compare data between multiple 
groups, and the one-way ANOVA to compare differences 
between cell types. Post hoc comparisons were made using 
Bonferroni’s (for two-way ANOVA) and Dunnett’s (for 
one-way ANOVA) multiple-comparison tests. A P value 
less than 0.05 was considered to be significant. Unless 
otherwise indicated, data were plotted using KaleidaGraph 
4.1 (Synergy Software, PA, US). 
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